Spots Global Cancer Trial Database for pancreatic polypeptide tumor

Every month we try and update this database with for pancreatic polypeptide tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors	NCT00075439	Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Recurrent Gastr... Recurrent Islet... Somatostatinoma WDHA Syndrome	gefitinib laboratory biom...	18 Years -	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors	NCT00602082	Gastrointestina... Islet Cell Tumo...	capecitabine cisplatin streptozocin DNA analysis RNA analysis protein analysi... proteomic profi... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum	NCT00005860	Cancer	floxuridine leucovorin calc... oxaliplatin	18 Years -	National Cancer Institute (NCI)
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	NCT01010126	Adult Hepatocel... Advanced Adult ... Endometrial Ser... Localized Non-R... Lung Carcinoid ... Malignant Pancr... Malignant Pancr... Malignant Pancr... Malignant Pancr... Metastatic Dige... Ovarian Carcino... Ovarian Endomet... Ovarian Seromuc... Ovarian Serous ... Pancreatic Alph... Pancreatic Beta... Pancreatic Delt... Pancreatic G-Ce... Pancreatic Poly... Recurrent Adult... Recurrent Diges... Recurrent Fallo... Recurrent Ovari... Recurrent Pancr... Recurrent Prima... Recurrent Uteri... Regional Digest... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino...	Bevacizumab Temsirolimus	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery	NCT00416767	Gastrointestina... Islet Cell Tumo... Neoplastic Synd...	fluorouracil irinotecan hydr... leucovorin calc...	18 Years - 80 Years	Federation Francophone de Cancerologie Digestive
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors	NCT00227617	Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... Neuroendocrine ...	bevacizumab 5-fluorouracil leucovorin oxaliplatin	18 Years -	University of California, San Francisco
Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors	NCT00027638	Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd...	thalidomide	-	Memorial Sloan Kettering Cancer Center
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors	NCT00227773	Gastrointestina... Islet Cell Carc...	octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors	NCT02259725	Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... Somatostatinoma	regorafenib laboratory biom...	18 Years -	University of Southern California
Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors	NCT00027638	Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd...	thalidomide	-	Memorial Sloan Kettering Cancer Center
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer	NCT02273752	Estrogen Recept... Gastrinoma Glucagonoma HER2-negative B... Insulinoma Mucositis Oral Complicati... Pancreatic Poly... Progesterone Re... Recurrent Breas... Recurrent Islet... Recurrent Renal... Somatostatinoma Stage III Renal... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Renal ...	Everolimus	18 Years -	Emory University
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors	NCT00075439	Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Recurrent Gastr... Recurrent Islet... Somatostatinoma WDHA Syndrome	gefitinib laboratory biom...	18 Years -	National Cancer Institute (NCI)
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors	NCT00466856	Head and Neck C... Islet Cell Tumo... Metastatic Canc... Pheochromocytom...	octreotide acet... yttrium Y 90 re...	18 Years -	Vanderbilt-Ingram Cancer Center
Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors	NCT02108782	Gastrinoma Glucagonoma Insulinoma Pancreatic Poly... Recurrent Islet... Somatostatinoma	dovitinib lacta... pharmacological... laboratory biom...	18 Years -	Academic and Community Cancer Research United
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors	NCT00131911	Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Neuroendocrine ... Pancreatic Poly... Recurrent Gastr... Recurrent Islet... Somatostatinoma WDHA Syndrome	sorafenib tosyl...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery	NCT00416767	Gastrointestina... Islet Cell Tumo... Neoplastic Synd...	fluorouracil irinotecan hydr... leucovorin calc...	18 Years - 80 Years	Federation Francophone de Cancerologie Digestive
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors	NCT00427349	Gastrointestina... Islet Cell Tumo... Neoplastic Synd...	AMG 706 octreotide	18 Years -	Eastern Cooperative Oncology Group
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors	NCT00427349	Gastrointestina... Islet Cell Tumo... Neoplastic Synd...	AMG 706 octreotide	18 Years -	Eastern Cooperative Oncology Group
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors	NCT00227773	Gastrointestina... Islet Cell Carc...	octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors	NCT02259725	Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... Somatostatinoma	regorafenib laboratory biom...	18 Years -	University of Southern California
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer	NCT00006368	Brain and Centr... Breast Cancer Gastrointestina... Islet Cell Tumo... Lung Cancer Lymphoma Melanoma (Skin) Neoplastic Synd...	yttrium Y 90-ed...	18 Years -	Novartis
Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors	NCT00084461	Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... Regional Gastro... Somatostatinoma	romidepsin laboratory biom...	18 Years -	National Cancer Institute (NCI)
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery	NCT02031536	Gastrinoma Glucagonoma Insulinoma Liver Metastase... Pancreatic Poly... Recurrent Islet... Somatostatinoma	everolimus placebo	18 Years -	Eastern Cooperative Oncology Group
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer	NCT00096083	Cancer	isolated perfus... melphalan	16 Years -	Delcath Systems Inc.
Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors	NCT00084461	Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... Regional Gastro... Somatostatinoma	romidepsin laboratory biom...	18 Years -	National Cancer Institute (NCI)
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors	NCT01525082	Gastrinoma Glucagonoma Insulinoma Pancreatic Poly... Recurrent Islet... Recurrent Pancr... Somatostatinoma Stage III Pancr... Stage IV Pancre...	Capecitabine Temozolomide Bevacizumab	18 Years -	Stanford University
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors	NCT01824875	Gastrinoma Glucagonoma Insulinoma Islet Cell Carc... Pancreatic Poly... Recurrent Islet... Somatostatinoma	temozolomide capecitabine	18 Years -	Eastern Cooperative Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: